Pages that link to "Q46253129"
Jump to navigation
Jump to search
The following pages link to Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology (Q46253129):
Displaying 50 items.
- Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatment (Q26738359) (← links)
- Radio(chemo)therapy in locally advanced nonsmall cell lung cancer (Q26765355) (← links)
- Radiation dose effect in locally advanced non-small cell lung cancer (Q26823043) (← links)
- Novel approaches of chemoradiotherapy in unresectable stage IIIA and stage IIIB non-small cell lung cancer (Q26827571) (← links)
- Concurrent systemic therapy with radiotherapy for the treatment of poor-risk patients with unresectable stage III non-small-cell lung cancer: a review of the literature (Q26851579) (← links)
- 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer (Q27002509) (← links)
- Maintenance chemotherapy for advanced non-small-cell lung cancer: new life for an old idea (Q27011282) (← links)
- 50 Years of progress in the systemic therapy of non-small cell lung cancer (Q27014978) (← links)
- Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab (Q29620596) (← links)
- The effect of consolidation chemotherapy after concurrent chemoradiotherapy on the survival of patients with locally advanced non-small cell lung cancer: a meta-analysis (Q30239983) (← links)
- Improving survival of patients with locally advanced non-small-cell cancer remains a challenge: comment to PROCLAIM. (Q30382413) (← links)
- Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data (Q30871677) (← links)
- Prospective Study of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Concurrent With Individualized Radiotherapy for Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer (Q33394279) (← links)
- A phase II single-arm study of induction chemotherapy with cisplatin and gemcitabine followed by concurrent cisplatin and gemcitabine with thoracic radiation for unresectable locally advanced non-small cell lung cancer (Q33407408) (← links)
- Phase 2 study of pemetrexed plus carboplatin, or pemetrexed plus cisplatin with concurrent radiation therapy followed by pemetrexed consolidation in patients with favorable-prognosis inoperable stage IIIA/B non-small-cell lung cancer (Q33410020) (← links)
- Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non-small cell lung cancer. (Q33412557) (← links)
- Phase II study of concurrent chemoradiotherapy with carboplatin and vinorelbine for locally advanced non-small-cell lung cancer (Q33414911) (← links)
- Multidisciplinary team approach for the management of patients with locally advanced non-small cell lung cancer: searching the evidence to guide the decision (Q33583931) (← links)
- A phase I study of concurrent individualized, isotoxic accelerated radiotherapy and cisplatin-vinorelbine-cetuximab in patients with stage III non-small-cell lung cancer (Q34041735) (← links)
- Going past the data for temozolomide (Q34093083) (← links)
- L-BLP25 as a peptide vaccine therapy in non-small cell lung cancer: a review (Q34430511) (← links)
- CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma (Q34466023) (← links)
- Concurrent chemoradiotherapy with tomotherapy in locally advanced Non-Small Cell Lung Cancer: a phase I, docetaxel dose-escalation study, with hypofractionated radiation regimen (Q34493493) (← links)
- Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancer (Q34672375) (← links)
- Clinical Responses and Prognostic Indicators of Concurrent Chemoradiation for Non-small Cell Lung Cancer (Q34771247) (← links)
- A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer (Q35134354) (← links)
- Prognostic value and reproducibility of pretreatment CT texture features in stage III non-small cell lung cancer. (Q35146660) (← links)
- Opportunistic illnesses in Brazilian children with AIDS: results from two national cohort studies, 1983-2007. (Q35147409) (← links)
- Concurrent chemoradiotherapy with vinorelbine plus split-dose cisplatin may be an option in inoperable stage III non-small cell lung cancer: a single-center experience (Q35167387) (← links)
- Randomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: Cancer and Leukemia Group B trial 30407. (Q35170255) (← links)
- Comparison of platinum combination re-challenge therapy and docetaxel monotherapy in non-small cell lung cancer patients previously treated with platinum-based chemoradiotherapy (Q35397008) (← links)
- Outcomes After Combined Modality Therapy forEGFR-Mutant and Wild-Type Locally Advanced NSCLC (Q35584972) (← links)
- Consolidation chemotherapy may improve survival for patients with locally advanced non-small-cell lung cancer receiving concurrent chemoradiotherapy--retrospective analysis of 203 cases (Q35810871) (← links)
- A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533 (Q35836792) (← links)
- A single-nucleotide polymorphism in the methylene tetrahydrofolate reductase (MTHFR) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy (Q35854707) (← links)
- Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer (Q35874455) (← links)
- Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer (Q35971034) (← links)
- A phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cisplatin for dry stage III non-small-cell lung cancer (JCOG9901DI). (Q35996196) (← links)
- A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (Q35999362) (← links)
- The importance of multidisciplinary team management of patients with non-small-cell lung cancer (Q36040638) (← links)
- Treatment-Related Death during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Studies (Q36051895) (← links)
- The role of docetaxel in the treatment of non-small cell lung cancer lung cancer: an update (Q36142491) (← links)
- Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy (Q36776988) (← links)
- The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801. (Q36823982) (← links)
- Chemoradiation for definitive, preoperative, or postoperative therapy of locally advanced non-small cell lung cancer (Q36989648) (← links)
- Combined radio- and chemotherapy for non-small cell lung cancer: systematic review of landmark studies based on acquired citations (Q36993644) (← links)
- Consolidation chwemotherapy after concurrent chemoradiotherapy vs. chemoradiotherapy alone for locally advanced unresectable stage III non-small-cell lung cancer: A meta-analysis (Q37108127) (← links)
- EGFR inhibition in non-small cell lung cancer: current evidence and future directions (Q37180302) (← links)
- Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial (Q37227687) (← links)
- Phase II Trial of Induction Gemcitabine and Carboplatin Followed by Conformal Thoracic Radiation to 74 Gy with Weekly Paclitaxel and Carboplatin in Unresectable Stage III Non-small Cell Lung Cancer (Q37339650) (← links)